Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
AMRUTANJAN
₹535
₹535.00
₹559.95
₹486.00
₹790.95
Markets Today
Historical Performance
As of 10-07-2026 22:21, Amrutanjan Health Care Ltd. share price today is ₹0, with a change of ₹-535.55 (-100.00%) from the previous close of ₹535.55. The stock opened at ₹535.2 and traded between ₹535 and ₹559.95, with a total traded volume of 97005 shares. The company has a market capitalization of ₹1548.3 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹790.95 and ₹486, respectively.
Amrutanjan Health Care Ltd. valuation metrics include a P/E ratio of 26.7, and book value of ₹4.20. Profitability indicators show ROE of 15.64% along with a dividend yield of 0.9%. Amrutanjan Health Care Ltd. has reported revenue of ₹502.55 Cr and net profit of ₹57.92 Cr.
Amrutanjan Health Care Ltd. technical indicators include Day RSI at 43.47, Day MFI at 22.2, Day ADX at 11.26. Additional indicators include Commodity Channel Index (CCI) at -80.6 and Williams %R at -83.16. Momentum indicators show Day MACD at -4.51, Day MACD Signal Line at -3.87, DayATR at 16.02. Rate of Change indicators for Amrutanjan Health Care Ltd. include ROC125 at -20.39 and ROC21 at -4.55.
Exponential moving averages include EMA5 at ₹537.4, EMA10 at ₹539.7, EMA12 at ₹540.5, EMA20 at ₹543.4, EMA26 at ₹545, EMA50 at ₹550.2, EMA100 at ₹566.6, EMA200 at ₹600.2. Simple moving averages include SMA5 at ₹536.3, SMA10 at ₹540, SMA20 at ₹544, SMA30 at ₹548.1, SMA50 at ₹553, SMA100 at ₹557.1, SMA150 at ₹585.7, SMA200 at ₹618.9.
Support levels for Amrutanjan Health Care are placed at First Support ₹530.83, Second Support ₹526.12, Third Support ₹518.68. Resistance levels are seen at First Resistance ₹542.98, Second Resistance ₹550.42, Third Resistance ₹555.13. Amrutanjan Health Care Ltd. shareholding pattern shows promoter holding at 46.52%, FII holding at 2.17%, DII holding at 0%, public holding at 38.61%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 149.77 | 141.04 | 117.70 | 94.05 | 135.41 |
| Operating Expense | 124.23 | 115.87 | 101.17 | 85.60 | 117.71 |
| Operating Profit | 25.54 | 25.17 | 16.53 | 8.45 | 17.70 |
| Depreciation | 1.61 | 1.62 | 1.56 | 1.53 | 1.62 |
| Interest | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 |
| Tax | 4.82 | 6.91 | 5.25 | 2.98 | 5.68 |
| Net Profit | 16.19 | 19.45 | 13.96 | 8.31 | 15.18 |
₹535.00
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 46.5 | 46.5 | 46.5 | 46.5 | 46.5 | 46.5 |
| FII | 2.3 | 2.3 | 2.4 | 2.4 | 2.3 | 2.2 |
| DII | 11.1 | 11.4 | 12.7 | 12.9 | 13 | 12.6 |
| Public | 40 | 39.8 | 38.3 | 38.2 | 38.2 | 38.6 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 13.35 K | 26.47 K | 50.44% |
| Week | 1.63 L | 2.17 L | 74.84% |
| 1 Month | 65.99 K | 91.17 K | 72.38% |
| 6 Month | 25.09 K | 38.01 K | 66.01% |
Companies with no Debt
Benjamin Graham Value Screen
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Mid-range Performer (DVM)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Increasing Revenue every quarter for the past 3 quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 06 Feb, 2026 | 1 | INTERIM | 07 Feb, 2026 | Equity Share |
| 18 Nov, 2025 | 1 | INTERIM | 18 Nov, 2025 | Equity Share |
| 16 Sep, 2025 | 2.6 | FINAL | 16 Sep, 2025 | Equity Share |
| 18 Feb, 2025 | 1 | INTERIM | 18 Feb, 2025 | Equity Share |
| 22 Nov, 2024 | 1 | INTERIM | 22 Nov, 2024 | Equity Share |
| 13 Sep, 2024 | 2.6 | FINAL | Equity Share | |
| 20 Feb, 2024 | 1 | INTERIM | 20 Feb, 2024 | Equity Share |
| 23 Nov, 2023 | 1 | INTERIM | 23 Nov, 2023 | Equity Share |
| 14 Sep, 2023 | 2.6 | FINAL | 14 Sep, 2023 | Equity Share |
| 24 Feb, 2023 | 1 | INTERIM | 24 Feb, 2023 | Equity Share |
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹587.60 | ₹5.40 | ₹179.17 | ₹15.60 | ₹62 |
| % Change | -1.43% | -0.18% | -2.00% | 0.84% | -0.26% |
| Revenue TTM (₹ Cr) | - | ₹83.60 | ₹287.68 | ₹176.50 | ₹237.47 |
| Net Profit TTM (₹ Cr) | - | ₹-34.95 | ₹14.88 | ₹27.81 | ₹-3.28 |
| PE TTM | - | -1.30 | 47.70 | 29.60 | -103.00 |
| 1 Year Return | 52.07 | 441 | 45.1 | 70 | -41.91 |
| ROCE | 3.56 | -5.63 | - | 17.36 | 0.77 |
Sigachi Industries Ltd.
₹ 22.67
+1.98%
Windlas Biotech Ltd.
₹ 830.00
+0.50%
Vineet Laboratories Ltd.
₹ 32.80
+0.43%
Solara Active Pharma Sciences Ltd.
₹ 568.90
+0.36%
Zim Laboratories Ltd.
₹ 113.62
-1.99%
Medico Remedies Ltd.
₹ 39.10
+0.03%
Dishman Carbogen Amcis Ltd.
₹ 195.49
+1.38%
Lasa Supergenerics Ltd.
₹ 7.52
+1.21%
Advanced Enzyme Technologies Ltd.
₹ 330.00
+1.74%
Bajaj Healthcare Ltd.
₹ 345.50
-1.31%
Ortin Global Ltd.
₹ 16.50
+1.10%
Brooks Laboratories Ltd.
₹ 69.90
-0.87%
RPG Life Sciences Ltd.
₹ 2861.10
+7.69%
Bafna Pharmaceuticals Ltd.
₹ 204.61
+2.00%
Alpa Laboratories Ltd.
₹ 68.70
+0.60%
SMS Pharmaceuticals Ltd.
₹ 403.00
-0.99%
Nectar Lifesciences Ltd.
₹ 11.21
-0.18%
Mangalam Drugs and Organics Ltd.
₹ 27.75
+1.80%
Indoco Remedies Ltd.
₹ 259.00
+1.53%
Ind-Swift Laboratories Ltd.
₹ 247.05
+4.87%
Lincoln Pharmaceuticals Ltd.
₹ 612.00
+0.01%
Panacea Biotec Ltd.
₹ 546.00
-1.66%
Medicamen Biotech Ltd.
₹ 244.00
-0.57%
Themis Medicare Ltd.
₹ 117.59
+1.33%
By signing up I certify terms, conditions & privacy policy